V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330011547 | 330004437 | 1.62 | 60.2 | Curative (C) | 2016-02-28 | 2016-03-05 | BENDAMUSTINE + RITUXIMAB | N | N | 330011960 | BENDAMUSTINE + RITUXIMAB |
| 330011548 | 330004438 | 1.56 | 76.8 | Curative (C) | 2014-08-16 | 2014-08-16 | ALL UKALL 2011 HD MtxB (Protocol M) | N | Y | 330011961 | UKALL2011 |
| 330011549 | 330004441 | null | 63.65 | Curative (C) | 2014-04-18 | 2014-05-02 | Carboplatin + Etoposide iv&po | 02 | N | 330011962 | CARBOPLATIN + ETOPOSIDE |
| 330011550 | 330004444 | 1.85 | 35.1 | Palliative (P) | 2017-12-07 | 2018-09-27 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330011964 | CARBOPLATIN + PACLITAXEL |
| 330011551 | 330010566 | 1.68 | 74.2 | Curative (C) | 2018-10-05 | 2018-10-05 | Carboplatin + Etoposide iv&po | 02 | N | 330011981 | CARBOPLATIN + ETOPOSIDE |
| 330011552 | 330004452 | 1.83 | 45 | Curative (C) | 2019-01-19 | 2019-01-25 | EURAMOS TRIAL | 2 | N | 330011990 | EURAMOS TRIAL |
| 330011553 | 330004453 | 1.63 | 50.7 | Palliative (P) | 2015-12-31 | 2016-09-24 | Carbo F | 1 | N | 330012004 | CARBO + FLUOROURACIL |
| 330011554 | 330004455 | 1.65 | null | Palliative (P) | 2016-01-27 | 2016-02-04 | Carboplatin + Paclitaxel (3 weekly) | null | N | 330012032 | CARBOPLATIN + PACLITAXEL |
| 330011555 | 330008427 | 0 | 76.8 | Curative (C) | 2013-04-03 | 2013-04-06 | ALL UKALL2011 Maintenance C1 | N | N | 330012034 | UKALL2011 |
| 330011556 | 330010571 | 1.77 | null | Curative (C) | 2016-07-04 | 2017-02-23 | CARBOPLATIN + RT | 02 | N | 330012071 | CARBOPLATIN + RT |
| 330011557 | 330004463 | null | 46.3 | Palliative (P) | 2016-03-08 | 2016-03-22 | EURAMOS TRIAL | 2 | null | 330012074 | EURAMOS TRIAL |
| 330011558 | 330008447 | 1.73 | 72.8 | Curative (C) | 2013-11-26 | 2014-04-17 | VAI (Ifos 3g/m2) | N | N | 330012199 | VAI |
| 330011559 | 330004488 | 1.6 | null | Palliative (P) | 2016-03-23 | 2016-10-14 | EURAMOS TRIAL | N | N | 330012203 | EURAMOS TRIAL |
| 330011560 | 330010581 | 1.52 | 35 | Palliative (P) | 2016-11-07 | 2016-11-19 | Carbo F | N | N | 330012256 | CARBO + FLUOROURACIL |
| 330011561 | 330004501 | 1.75 | 53.9 | Palliative (P) | 2014-02-20 | 2014-02-20 | Paclitaxel (2 or 3 weekly) | N | N | 330012261 | PACLITAXEL |
| 330011562 | 330004503 | 1.6 | null | Neo-adjuvant (N) | 2019-07-27 | 2019-08-14 | VAI (Ifos 3g/m2) | N | N | 330012272 | VAI |
| 330011563 | 330004509 | 1.8 | 65.2 | Palliative (P) | 2013-11-01 | 2013-11-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 330012287 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330011564 | 330004515 | 1.72 | 61 | Curative (C) | 2014-05-05 | 2014-05-11 | CARBOPLATIN + RT | 02 | N | 330012305 | CARBOPLATIN + RT |
| 330011565 | 330004519 | 1.7 | 103 | Palliative (P) | 2015-10-23 | 2015-11-04 | ALL UKALL 2011 HD MtxB (Protocol M) | N | N | 330012324 | UKALL2011 |
| 330011566 | 330004524 | 1.7 | 63 | Palliative (P) | 2018-04-03 | 2018-07-08 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330012345 | CARBOPLATIN + PACLITAXEL |
| 330011567 | 330004528 | 1.53 | 63.4 | Palliative (P) | 2016-05-30 | 2016-06-13 | BENDAMUSTINE + RITUXIMAB | N | N | 330012351 | BENDAMUSTINE + RITUXIMAB |
| 330011568 | 330004529 | 1.72 | 80.9 | Neo-adjuvant (N) | 2014-03-07 | 2014-03-15 | BENDAMUSTINE + RITUXIMAB | N | N | 330012352 | BENDAMUSTINE + RITUXIMAB |
| 330011569 | 330004534 | 1.78 | null | Palliative (P) | 2013-05-24 | 2014-12-29 | EURAMOS TRIAL | N | N | 330012372 | EURAMOS TRIAL |
| 330011570 | 330004536 | 1.55 | 70.4 | Palliative (P) | 2018-10-22 | 2018-11-01 | VAI (Ifos 3g/m2) | 02 | N | 330012373 | VAI |
| 330011571 | 330004539 | 1.47 | 19.7 | Curative (C) | 2017-04-19 | 2017-04-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330012378 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330011572 | 330004540 | 1.66 | 85.6 | null | 2017-10-06 | 2017-10-07 | Paclitaxel (2 or 3 weekly) | 02 | N | 330012379 | PACLITAXEL |
| 330011573 | 330008476 | 1.7 | 74.8 | Curative (C) | 2014-11-15 | 2014-11-26 | CARBOPLATIN + ETOPOSIDE | null | Y | 330012382 | CARBOPLATIN + ETOPOSIDE |
| 330011574 | 330004546 | null | null | Palliative (P) | null | 2015-01-13 | EURAMOS TRIAL | null | null | 330012397 | EURAMOS TRIAL |
| 330011575 | 330004548 | 1.69 | 80.1 | Neo-adjuvant (N) | 2015-05-17 | 2017-12-27 | Carbo F | 2 | N | 330012411 | CARBO + FLUOROURACIL |
| 330011576 | 330008482 | 1.76 | 70 | Neo-adjuvant (N) | 2019-12-12 | 2019-12-12 | Carbo F | N | N | 330012437 | CARBO + FLUOROURACIL |
| 330011577 | 330004555 | null | 7.9 | Palliative (P) | 2018-10-17 | 2018-10-22 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 330012450 | PACLITAXEL |
| 330011578 | 330008491 | 1.64 | 60 | Palliative (P) | 2013-07-14 | 2014-02-07 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330012515 | CARBO + FLUOROURACIL |
| 330011579 | 330004569 | 1.68 | 69.8 | Curative (C) | 2014-11-30 | 2014-12-07 | CARBOPLATIN + RT | 02 | N | 330012532 | CARBOPLATIN + RT |
| 330011580 | 330004571 | 1.61 | 54.1 | Curative (C) | 2018-05-01 | 2018-05-05 | CARBOPLATIN + RT | 02 | N | 330012540 | CARBOPLATIN + RT |
| 330011581 | 330004573 | 1.59 | null | Disease modification (D) | 2013-10-05 | 2013-11-05 | CARBOPLATIN + RT | N | Y | 330012542 | CARBOPLATIN + RT |
| 330011582 | 330004579 | 1.85 | 70 | Curative (C) | null | 2018-07-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330012557 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330011583 | 330004581 | null | 78.6 | Palliative (P) | null | 2015-11-30 | CARBOPLATIN + FLUOROURACIL | N | N | 330012562 | CARBO + FLUOROURACIL |
| 330011584 | 330010602 | 1.61 | 46.3 | Palliative (P) | 2017-09-01 | 2017-12-09 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | Y | 330012594 | PACLITAXEL |
| 330011585 | 330008504 | 1.69 | null | Neo-adjuvant (N) | 2014-01-22 | 2014-02-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330012604 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330011587 | 330004594 | null | null | Palliative (P) | 2015-03-08 | 2015-04-15 | CARBOPLATIN + PACLITAXEL | N | Y | 330012615 | CARBOPLATIN + PACLITAXEL |
| 330011588 | 330004596 | 0 | 61.6 | Palliative (P) | 2016-10-19 | 2017-01-04 | ALL UKALL2011 Del Int C Reind PAsp | N | N | 330012618 | UKALL2011 |
| 330011589 | 330008510 | 1.62 | 76.7 | Curative (C) | 2019-02-10 | 2019-04-10 | CNS GCT II Germinoma - Carbo Etop | 02 | N | 330012634 | CARBOPLATIN + ETOPOSIDE |
| 330011590 | 330004606 | 1.7 | 80 | Neo-adjuvant (N) | 2016-10-21 | 2017-07-16 | CARBOPLATIN + RT | 02 | N | 330012642 | CARBOPLATIN + RT |
| 330011592 | 330008514 | 1.71 | 95.8 | Palliative (P) | 2018-06-19 | 2018-06-19 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330012673 | CARBOPLATIN + PACLITAXEL |
| 330011593 | 330004626 | 1.73 | 52.1 | Palliative (P) | 2014-11-09 | 2014-11-10 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 330012730 | PACLITAXEL |
| 330011594 | 330004634 | 1.75 | 61 | Curative (C) | 2015-02-04 | 2015-02-07 | VAI (Ifos 3g/m2) | 2 | null | 330012785 | VAI |
| 330011595 | 330004639 | 1.73 | 76.2 | Disease modification (D) | 2014-11-18 | 2014-11-18 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330012805 | BENDAMUSTINE + RITUXIMAB |
| 330011596 | 330004643 | 1.81 | 87.6 | Palliative (P) | 2015-06-15 | 2015-08-17 | Carbo F | N | N | 330012816 | CARBO + FLUOROURACIL |
| 330011597 | 330004645 | 1.6 | null | Palliative (P) | 2014-03-14 | 2014-03-30 | VAI (Ifos 3g/m2) | N | Y | 330012823 | VAI |
| 330011598 | 330010622 | 1.75 | 30.2 | Curative (C) | 2015-11-22 | 2015-11-22 | CARBOPLATIN + RT | N | N | 330012858 | CARBOPLATIN + RT |